NO890260L - Fremgangsmaate ved fremstilling av cytostatin c eller modifikasjoner derav og dna-sekvens for anvendelse ved utfoerelse av fremgangsmaaten. - Google Patents

Fremgangsmaate ved fremstilling av cytostatin c eller modifikasjoner derav og dna-sekvens for anvendelse ved utfoerelse av fremgangsmaaten.

Info

Publication number: NO890260L
Authority: NO; Norway
Prior art keywords: procedure; cytostatin; preparing; carrying; modifications
Prior art date: 1987-05-22

Application number

NO89890260A

Other languages

English (en)

Other versions

NO890260D0 (no

NO301985B1 (no

Inventor

Anders Grubb

Ke Lundwall

Magnus Abrahamson

Henrik Dalboege

Original Assignee

Nordisk Gentofte

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-05-22

Filing date

1989-01-20

Publication date

1989-01-20

1989-01-20 Application filed by Nordisk Gentofte filed Critical Nordisk Gentofte

1989-01-20 Publication of NO890260D0 publication Critical patent/NO890260D0/no

1989-01-20 Publication of NO890260L publication Critical patent/NO890260L/no

1998-01-05 Publication of NO301985B1 publication Critical patent/NO301985B1/no

Links

238000000034 method Methods 0.000 title 2
PQNNIEWMPIULRS-UHFFFAOYSA-N Cytostatin Natural products CC=CC=CC=CC(O)C(C)C(OP(O)(O)=O)CCC(C)C1OC(=O)C=CC1C PQNNIEWMPIULRS-UHFFFAOYSA-N 0.000 title 1
108091028043 Nucleic acid sequence Proteins 0.000 title 1
PQNNIEWMPIULRS-SUTYWZMXSA-N [(8e,10e,12e)-7-hydroxy-6-methyl-2-(3-methyl-6-oxo-2,3-dihydropyran-2-yl)tetradeca-8,10,12-trien-5-yl] dihydrogen phosphate Chemical compound C\C=C\C=C\C=C\C(O)C(C)C(OP(O)(O)=O)CCC(C)C1OC(=O)C=CC1C PQNNIEWMPIULRS-SUTYWZMXSA-N 0.000 title 1
238000012986 modification Methods 0.000 title 1
102000012192 Cystatin C Human genes 0.000 abstract 4
108010061642 Cystatin C Proteins 0.000 abstract 4
108020004705 Codon Proteins 0.000 abstract 1
210000004027 cell Anatomy 0.000 abstract 1
239000002299 complementary DNA Substances 0.000 abstract 1
238000012258 culturing Methods 0.000 abstract 1
210000005260 human cell Anatomy 0.000 abstract 1
244000005700 microbiome Species 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Heart & Thoracic Surgery (AREA)
Molecular Biology (AREA)
Cardiology (AREA)
Virology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Vascular Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Dermatology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Electronic Switches (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO890260A 1987-05-22 1989-01-20 Fremgangsmåte for fremstilling av 3-des-hydroksy-cystatin C eller en homolog derav, plasmid samt mikroorganisme for anvendelse ved utförelse av fremgangsmåten NO301985B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DK260987A DK260987D0 (da)	1987-05-22	1987-05-22	Fremgangsmaade til fremstilling af et humant protein samt dna-sekvens til anvendelse ved udoevelse af fremgangsmaaden
PCT/DK1988/000082 WO1988009384A1 (en)	1987-05-22	1988-05-20	Method of producing cystatin c or modifications hereof and dna-sequence for use when carrying out the method

Publications (3)

Publication Number	Publication Date
NO890260D0 NO890260D0 (no)	1989-01-20
NO890260L true NO890260L (no)	1989-01-20
NO301985B1 NO301985B1 (no)	1998-01-05

Family

ID=8113675

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO890260A NO301985B1 (no)	1987-05-22	1989-01-20	Fremgangsmåte for fremstilling av 3-des-hydroksy-cystatin C eller en homolog derav, plasmid samt mikroorganisme for anvendelse ved utförelse av fremgangsmåten

Country Status (12)

Country	Link
EP (1)	EP0362259B1 (no)
JP (1)	JP3011274B2 (no)
AT (1)	ATE135049T1 (no)
AU (1)	AU619750B2 (no)
CA (1)	CA1340862C (no)
DE (1)	DE3855078T2 (no)
DK (1)	DK260987D0 (no)
ES (1)	ES2013337A6 (no)
FI (1)	FI102191B (no)
IL (1)	IL86476A (no)
NO (1)	NO301985B1 (no)
WO (1)	WO1988009384A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2002820A1 (en) *	1988-11-18	1990-05-18	Kazunori Hanada	Pharmaceutical use for cystatins
GB9122051D0 (en) *	1991-10-17	1991-11-27	Univ Nottingham	Medicines
GB9403819D0 (en) *	1994-02-28	1994-04-20	Univ Leeds	Control of parasites
AU715747B2 (en) *	1994-11-21	2000-02-10	University Of Leeds, The	Modified proteinase inhibitors
AU738766B2 (en) *	1994-11-21	2001-09-27	University Of Leeds, The	Modified proteinase inhibitors
US6011012A (en)	1995-06-05	2000-01-04	Human Genome Sciences, Inc.	Human cystatin E
WO1996039418A1 (en) *	1995-06-05	1996-12-12	Human Genome Sciences, Inc.	Human cystatin e
CA2335344A1 (en) *	1998-08-05	2000-02-17	The University Of British Columbia	Production and use of modified cystatins
AU2178000A (en) *	1998-12-11	2000-06-26	Salk Institute For Biological Studies, The	Co-factors for trophic factors, and methods of use thereof
EP1176200A3 (de)	2000-06-20	2005-01-12	Switch Biotech Aktiengesellschaft	Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankung oder Wundheilung sowie ihre Verwendung zur Indentifizierung von pharmakologisch aktiven Substanzen
JP6203723B2 (ja) *	2012-07-31	2017-09-27	雪印メグミルク株式会社	骨疾患の予防又は治療用タンパク質素材及びその製造方法
CN102895658A (zh) *	2012-08-23	2013-01-30	苏州大学附属第一医院	Cystatin C在治疗蛛网膜下腔出血后发生的脑血管痉挛的应用
CN106119286A (zh) *	2016-08-10	2016-11-16	吴江近岸蛋白质科技有限公司	表达载体及其高效表达和制备人胱抑素c蛋白的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4775624A (en) *	1985-02-08	1988-10-04	Eli Lilly And Company	Vectors and compounds for expression of human protein C

1987
- 1987-05-22 DK DK260987A patent/DK260987D0/da not_active Application Discontinuation
1988
- 1988-05-20 AU AU19399/88A patent/AU619750B2/en not_active Expired
- 1988-05-20 JP JP63504682A patent/JP3011274B2/ja not_active Expired - Lifetime
- 1988-05-20 EP EP88904935A patent/EP0362259B1/en not_active Expired - Lifetime
- 1988-05-20 ES ES8801999A patent/ES2013337A6/es not_active Expired - Lifetime
- 1988-05-20 DE DE3855078T patent/DE3855078T2/de not_active Expired - Lifetime
- 1988-05-20 AT AT88904935T patent/ATE135049T1/de not_active IP Right Cessation
- 1988-05-20 WO PCT/DK1988/000082 patent/WO1988009384A1/en not_active Ceased
- 1988-05-23 IL IL8647688A patent/IL86476A/en not_active IP Right Cessation
- 1988-05-24 CA CA000567916A patent/CA1340862C/en not_active Expired - Lifetime
1989
- 1989-01-20 NO NO890260A patent/NO301985B1/no not_active IP Right Cessation
- 1989-11-21 FI FI895553A patent/FI102191B/fi not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0362259A1 (en)	1990-04-11
FI102191B1 (fi)	1998-10-30
NO890260D0 (no)	1989-01-20
ATE135049T1 (de)	1996-03-15
DE3855078D1 (de)	1996-04-11
WO1988009384A1 (en)	1988-12-01
IL86476A (en)	1994-01-25
ES2013337A6 (es)	1990-05-01
DE3855078T2 (de)	1996-07-18
JPH03501201A (ja)	1991-03-22
DK260987D0 (da)	1987-05-22
JP3011274B2 (ja)	2000-02-21
FI895553A0 (fi)	1989-11-21
CA1340862C (en)	1999-12-28
IL86476A0 (en)	1988-11-15
EP0362259B1 (en)	1996-03-06
AU619750B2 (en)	1992-02-06
AU1939988A (en)	1988-12-21
NO301985B1 (no)	1998-01-05
FI102191B (fi)	1998-10-30

Similar Documents

Publication	Publication Date	Title
NO890260L (no)	1989-01-20	Fremgangsmaate ved fremstilling av cytostatin c eller modifikasjoner derav og dna-sekvens for anvendelse ved utfoerelse av fremgangsmaaten.
FI922812A0 (fi)	1992-06-17	Stabil oeverfoering av dna till bakteriernas arvanslag.
DE3864585D1 (de)	1991-10-10	Dns-molekule, codierend fuer non-a-non-b-hepatitis-antigene und ihre verwendung zur herstellung dieser antigene.
DE69214438D1 (de)	1996-11-14	Mehrstufiger bestrahlungsprozess zur herstellung von zusammensetzungen auf acrylbasis, und derartig hergestellte zusammensetzungen
DE3888274D1 (de)	1994-04-14	Vorrichtung zur intensiven und kontrollierten Herstellung von Mikroorganismen durch Photosynthese.
DE69022595D1 (de)	1995-10-26	Herstellung von kohlefaser-halbfabrikaten.
ES2163392T3 (es)	2002-02-01	Nuevas secuencias expresadas preferentemente en el desarrollo de semillas precoces, y procedimientos relacionados con las mismas.
FI852547L (fi)	1985-06-27	Framstaellning av faktor viii och daertill hoerande produkter.
DE68929551D1 (de)	2007-05-10	Menschliche DNase
NO812776L (no)	1982-02-19	Anode for elektrolyseprosesser og fremgangsmaate ved fremstilling derav.
DE3872070D1 (de)	1992-07-23	Filter, das ein durch gefriertrocknung hergestelltes material enthaelt, herstellung und verwendung desselben, insbesondere in der galenik.
DE3560196D1 (en)	1987-07-02	Process for the preparation of 1,2,3-trichloro-2-methyl-1-propane
SE8800157D0 (sv)	1988-01-19	Transformation and foreign gene expression in brassica species
DE59003144D1 (de)	1993-11-25	Destillationsanlage zur Herstellung von Wasserstoff-Peroxid.
NO862657L (no)	1988-01-04	Fremgangsmÿte og anordning for bruk ved rensing av vannet i oppdrettsbeholdere for fisk.
IL83607A (en)	1992-05-25	Polypeptides of the rhinovirus strain hrv89 and the dna molecules coding therefor
ES2054230T3 (es)	1994-08-01	Un proceso para la preparacion de un enterovirus o rinovirus atenuado.
DE68924222D1 (de)	1995-10-19	Megakaryocytopoietin, seine Herstellung und Benutzung.
ATE109509T1 (de)	1994-08-15	Anticoagulatorisches protein pp4-x, seine herstellung und verwendung.
DK583589A (da)	1990-01-19	Fremgangsmaade til fremstilling af cystatin c eller modifikationer heraf og dna-sekvens til brug ved udoevelse af fremgangsmaaden
DE3768575D1 (de)	1991-04-18	Verwendung von haertbaren reaktionsmassen zur herstellung von datentraegern.
DE3882842D1 (de)	1993-09-09	Methode zur herstellung von cineolen.
ATE70260T1 (de)	1991-12-15	Verfahren zur herstellung von di-npropylacetonitril.
BG60169B2 (bg)	1993-11-30	Получаване на плурипотентен гранулоцитен колоний-стимулиращ фактор
DK622286A (da)	1987-06-25	Hydroxyalkylphenoxypropan-2-ol-3-amin og fremgangsmaade til fremstilling deraf

Legal Events

Date	Code	Title	Description
2008-06-23	MK1K	Patent expired